Psoriasis Clinical Trial

Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System

Summary

The objective of this study is to evaluate patient outcomes in regards to safety and effectiveness based on the clinical performance of the reference devices to further support the assessment of residual risk identified in the Clinical Evaluation Report for the Ortho Development Hip System.

View Full Description

Full Description

Long term surveillance of survivorship and complications can help to identify pre-surgical comorbidities, perhaps leading to a lower risk of implant failure and subsequent revision surgery. By understanding the role of comorbidities in the specific population, it is possible to increase patient outcomes and satisfaction, while reducing the costs associated with complications and revision surgeries.

This study consists of prospective collection and analysis of data for a consecutive series of patients that underwent total hip arthroplasty with the Ortho Development Ovation® Hip System at the study site between 2012 and December 2015. It is estimated that over 400 patients received the subject system. Each of these patients will receive a survey within the mail when they approach, or have exceeded, their five-year post-surgical time period.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient is at least 18 years of age
Patient is five years post total hip arthroplasty
Patient received the Ovation® or Ovation Tribute® femoral stem with associated acetabular and femoral components
Patient agrees to participate in the survey.

Exclusion Criteria:

Patient does not have the Ovation® or Ovation Tribute® femoral stem with associated acetabular and femoral components

Study is for people with:

Psoriasis

Estimated Enrollment:

400

Study ID:

NCT03986918

Recruitment Status:

Recruiting

Sponsor:

Ortho Development Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Straub Medical Center
Honolulu Hawaii, 96813, United States More Info
Samantha Andrews, PhD
Contact
808-522-4855
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

400

Study ID:

NCT03986918

Recruitment Status:

Recruiting

Sponsor:


Ortho Development Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider